For the record, it's pulmonary arterial hypertension, which is otherwise known as PAH, for short.
On October 25th, 2018. See this statement in context.
On October 25th, 2018. See this statement in context.
Jacqueline Dobson Government Affairs and Policy Manager, Government Affairs and Market Access, Janssen Inc. Pharmaceutical Companies of Johnson & Johnson
For the record, it's pulmonary arterial hypertension, which is otherwise known as PAH, for short.
See context to find out what was said next.